Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Partners in Caring for Anxious Youth
NCT04598230Phase 3Active, not recruiting
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Feb 2021
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluoxetine, sertraline, Escitalopram oxalate oral solution in separation anxiety disorder (SAD), generalized anxiety disorder (GAD), Social Anxiety Disorder (SAD), sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Started Feb 2021; status: active, not recruiting.
02
Drugs
fluoxetinesertralineEscitalopram oxalate oral solution
03
Conditions
separation anxiety disorder (SAD)generalized anxiety disorder (GAD)Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT04598230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04598230.